Identification of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba

Journal of Acquired Immune Deficiency Syndromes

Volumn 40, Issue 5, 2005, Pages 532-537

  Casado, Gema ^a   Thomson, Michael M ^a   Sierra, Maria ^a   Nájera, Rafael ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Africa; Circulating recombinant form; CRF19_cpx; Cuba; HIV 1; Subtypes

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ARTICLE; CONTROLLED STUDY; CUBA; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VIRUS CHARACTERIZATION; VIRUS IDENTIFICATION; VIRUS RECOMBINANT; VIRUS STRAIN;

ADULT; AFRICA; CUBA; FEMALE; GENES, ENV; GENES, POL; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 27944467433     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000186363.27587.c0     Document Type: Article

References (34)

1. Gao F, Bailes E, Robertson DL, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature. 1999;397:436-441.
2. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science. 2000;288:55-56.
3. Sequence Database HIV [database online]. Los Alamos, NM: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, 2004. Available at: http://www.hiv.lanl.gov, accessed October 6, 2005.
4. Thomson MM, Casado G, Sierra M, et al. Identification of novel complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba. AIDS. 2005;19:1155-1163.
5. Nájera R, Delgado E, Pérez-Álvarez L, et al. Genetic recombination and its role in the development of the HIV-1 pandemic. AIDS. 2002;16(Suppl 4):S3-S16.
6. Cuevas MT, Ruibal I, Villahermosa ML, et al. High HIV-1 genetic diversity in Cuba. AIDS. 2002;16:1643-1653.
7. Thomson MM, Delgado E, Herrero I, et al. Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J Gen Virol. 2002;83:107-119.
8. Sierra M, Thomson MM, Ríos M, et al. The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF. Infect Genet Evol. 2005;5:209-217.
9. Thompson JD, Gibson TJ, Plewniak F, et al. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997;25:4876-4882.
10. Salminen MO, Carr JK, Burke DS, et al. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses. 1995;11:1423-1425.
11. Lole KS, Bollinger RC, Paranjape RS, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73:152-160.
12. Kumar S, Tamura K, Nei M. MEGA3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform. 2004;5:150-163.
13. Hillis DM, Bull JJ. An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Syst Biol. 1993;42:182-192.
14. Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol. 1990;215:403-410.
15. Takebe Y, Motomura K, Tatsumi M, et al. High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar geographical hot spot of extensive recombination. AIDS. 2003;17:2077-2087.
16. Yang R, Xia X, Kusagawa S, et al. On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China. AIDS. 2002;16:1401-1407.
17. Thomson MM, Delgado E, Herrero I, et al. Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J Gen Virol. 2002;83:107-119.
18. Thomson MM, Sierra M, Tanuri A, et al. The analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF. AIDS Res Hum Retroviruses. 2004;20:1126-1133.
19. Dowling WE, Kim B, Mason CJ, et al. Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS. 2002;16:1809-1820.
20. Harris ME, Serwadda D, Sewankambo N, et al. Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate. AIDS Res Hum Retroviruses. 2002;18:1281-1290.
21. Carr JK, Torimiro JN, Wolfe ND, et al. The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. Virology. 2001;286:168-181.
22. Louwagie J, McCutchan FE, Peeters M, et al. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS. 1993;7:769-780.
23. Delaporte E, Janssens W, Peeters M, et al. 1996. Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994. AIDS. 1996;10:903-910.
24. Janssens W, Heyndrickx L, Fransen K, et al. Genetic and phylogenetic analysis of env subtypes G and H in central Africa. AIDS Res Hum Retroviruses. 1994;10:877-879.
25. Torres-Anjel MJ. Macroepidemiology of the HIVs-AIDS (HAIDS) pandemic: insufficiently considered zoological and geopolitical aspects. Ann NY Acad Sci. 1992;653:257-273.
26. Santana S, Faas L, Wald K. Human immunodeficiency virus in Cuba: the public health response of a Third World country. Int J Health Serv. 1991;21:511-537.
27. Mascola JR, Louwagie J, McCutchan FE, et al. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J Infect Dis. 1994;169:48-54.
28. Thomson MM, Pérez-Álvarez L, Nájera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis. 2002;2:461-471.
29. Binley JM, Wrin T, Korber B, et al. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol. 2004;78:13232-13252.
30. Amendola A, Bordi L, Angeletti C, et al. Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02). J Acquir Immune Defic Syndr. 2002;31:488-494.
31. Antunes R, Figueiredo S, Bartolo I, et al. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms. J Clin Microbiol. 2003;41:3361-3367.
32. Gottesman BS, Grosman Z, Lorber M, et al. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load. J Med Virol. 2004;73:167-171.
33. Kantor R, Katzenstein D. Drug resistance in non-subtype B HIV-1. J Clin Virol. 2004;29:152-159.
34. Wainberg MA. HIV-1 subtype distribution and the problem of drug resistance. AIDS. 2004;18(Suppl 3):S63-S68.